1. Home
  2. GBIO vs FGL Comparison

GBIO vs FGL Comparison

Compare GBIO & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • FGL
  • Stock Information
  • Founded
  • GBIO 2016
  • FGL 2021
  • Country
  • GBIO United States
  • FGL Malaysia
  • Employees
  • GBIO N/A
  • FGL N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • FGL
  • Sector
  • GBIO Health Care
  • FGL
  • Exchange
  • GBIO Nasdaq
  • FGL NYSE
  • Market Cap
  • GBIO 29.2M
  • FGL 25.4M
  • IPO Year
  • GBIO 2020
  • FGL 2024
  • Fundamental
  • Price
  • GBIO $0.33
  • FGL $0.81
  • Analyst Decision
  • GBIO Strong Buy
  • FGL
  • Analyst Count
  • GBIO 4
  • FGL 0
  • Target Price
  • GBIO $7.33
  • FGL N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • FGL 1.2M
  • Earning Date
  • GBIO 08-06-2025
  • FGL 07-15-2025
  • Dividend Yield
  • GBIO N/A
  • FGL N/A
  • EPS Growth
  • GBIO N/A
  • FGL N/A
  • EPS
  • GBIO N/A
  • FGL N/A
  • Revenue
  • GBIO $24,556,000.00
  • FGL $20,205,441.00
  • Revenue This Year
  • GBIO N/A
  • FGL N/A
  • Revenue Next Year
  • GBIO N/A
  • FGL N/A
  • P/E Ratio
  • GBIO N/A
  • FGL N/A
  • Revenue Growth
  • GBIO 146.47
  • FGL N/A
  • 52 Week Low
  • GBIO $0.30
  • FGL $0.66
  • 52 Week High
  • GBIO $3.65
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 42.78
  • FGL N/A
  • Support Level
  • GBIO $0.31
  • FGL N/A
  • Resistance Level
  • GBIO $0.36
  • FGL N/A
  • Average True Range (ATR)
  • GBIO 0.03
  • FGL 0.00
  • MACD
  • GBIO -0.00
  • FGL 0.00
  • Stochastic Oscillator
  • GBIO 27.27
  • FGL 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About FGL FOUNDER GROUP LTD

Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.

Share on Social Networks: